2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on IDH1-Mutated AML: How Tolerated is IVO/VEN/AZA Combination and What Are the Survival Outcomes?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Michael Deininger
By 2020 ASCO Virtual Direct™ Highlights FEATURING Michael Deininger
51 views
October 12, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Hematologic Oncology
08:07
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on R/R AML: Is AMG 330 Safe and Tolerable?

Feat. M. Deininger
10:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Newly Diagnosed AML: How Safe Is ENA+AZA Combina…

Feat. M. Deininger
06:41
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IDH1-Mutated AML: How Tolerated is IVO/VEN/AZA C…

Feat. M. Deininger
09:47
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on CML: How Does Ponatinib Dose Reduction Affect Re…

Feat. M. Deininger